Hunan Nucien Pharmaceutical Co., Ltd. (688189.SH): Guangzhou Qianyuan plans to reduce its holdings by no more than 3%.
ST South New (688189.SH) announced that due to funding needs, Guangzhou Qianyuan Investment Consulting Partnership (Limited Partnership) (referred to as "Guangzhou Qianyuan") plans to reduce its holdings of the company's shares through centralized bidding and block trading. The share reduction will take place within three months after the disclosure of the reduction plan, and the total number of shares to be reduced will not exceed 8.1849 million shares, which is no more than 3% of the company's total share capital.
Hunan Nucien Pharmaceutical Co., Ltd. (688189.SH) announced that due to funding needs, Guangzhou Qianyuan Investment Consulting Partnership (Limited Partnership) (referred to as "Guangzhou Qianyuan") intends to reduce its holdings of the company's shares through centralized bidding transactions and block trading. This reduction will occur within three months after the disclosure of the reduction plan, and the total number of shares to be reduced will not exceed 8.1849 million shares, accounting for no more than 3% of the company's total share capital.
Related Articles
CL GROUP (08098) has granted a loan amounting to HKD 4 million through its subsidiary.
.png)
Bichamp Cutting Technology (002843.SZ) plans to launch a stock option and restricted stock incentive plan in 2026.
CNBM (03323): Liu Biao has resigned as vice president.
CL GROUP (08098) has granted a loan amounting to HKD 4 million through its subsidiary.
Bichamp Cutting Technology (002843.SZ) plans to launch a stock option and restricted stock incentive plan in 2026.
CNBM (03323): Liu Biao has resigned as vice president.
RECOMMEND
